(Reuters) - European shares slipped on Wednesday as investors took stock following a near 14% rally last month, while shares in BioNTech surged after U.K. became the first country to approve its COVID-19 vaccine developed with Pfizer.
London’s blue-chip index outperformed regional peers, up 0.1% after Britain said the vaccine will be rolled out from next week, and as the pound slid on Brexit trade deal uncertainty.
The FTSE 100 has been inching towards pre-pandemic levels, having recovered 60% from March lows.
BioNtech’s Frankfurt-listed shares jumped 7.5%, compared with a 0.5% fall for Germany’s benchmark DAX index.
Data showing a higher-than-expected rebound in retail sales in Europe’s largest economy in October did little to cheer investors.
The pan-European STOXX 600 index was down 0.3%, with auto stocks leading declines as carmaker Volkswagen slipped 2.1% amid uncertainty about top management.
Read more from the original article:
https://www.reuters.com/articl...
風險提示：本文所述僅代表作者個人觀點，不代表 Followme 的官方立場。Followme 不對內容的準確性、完整性或可靠性作出任何保證，對於基於該內容所採取的任何行為，不承擔任何責任，除非另有書面明確說明。
暫無評論，立馬搶沙發